ERF
protein-codingETS2 repressor factor, the group of ETS transcription factor family
Gene summary
ETS2 is a transcription factor and protooncogene involved in development, apoptosis, and the regulation of telomerase. The protein encoded by this gene binds to the ETS2 promoter and is a strong repressor of ETS2 transcription. Several transcript variants encoding two different isoforms have been found for this gene. [provided by RefSeq, Aug 2015]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~7.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AD
Disease ID:MONDO:0010929
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0010929
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0014956
Submitter: G2P
Inheritance Pattern: AD
Disease ID:MONDO:0018997
Submitter: PanelApp Australia
Inheritance Pattern: AD
Disease ID:MONDO:0014956
Submitter: Ambry Genetics
Inheritance Pattern: AD
Disease ID:MONDO:0010929
Submitter: Genomics England PanelApp
Inheritance Pattern: AD
Disease ID:MONDO:0010929
Submitter: ClinGen
ERF was first reported in relation to autosomal dominant ERF-related craniosynostosis in 2013 (Twigg et al., PMID: 23354439). The phenotypic features of "ERF-related craniosynostosis" often include sagittal or multiple-suture synostosis, Chiari malformation, and language delay. Per criteria outlined by the ClinGen Lumping and Splitting Working Group, we found differences in the phenotypic and genotypic variability between ERF-related craniosynostosis and Chitayat syndrome. Therefore, the two disease entities have been split. The split curation for autosomal dominant Chitayat syndrome will be curated separately. Ten variants (missense, nonsense, splice, frameshift) that have been reported in 12 probands in 3 publications (PMIDs: 23354439, 26097063, 31754721) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be heterozygous loss of function (haploinsufficiency) (PMID: 23354439). This gene-disease association is supported by an expression study and a conditional mouse model (PMID: 23354439). In summary, ERF is definitively associated autosomal dominant ERF-related craniosynostosis. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Craniofacial Malformations GCEP on the meeting date 5/20/2021.
Inheritance Pattern: AD
Disease ID:MONDO:0010929
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0014956
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal; Neurologic; Pulmonary
Intervention: Pulmonary
Rationale: Among other features, Chitayat syndrome can include neonatal respiratory distress requiring ventilatory support, and awareness may allow early recognition and management
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to ERF variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006494.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 3 | 52 | 5 | 60 | ||
| missense | 1 | 8 | 162 | 18 | 1 | 190 |
| nonsense | 8 | 10 | 1 | 19 | ||
| start loss | 2 | 1 | 3 | |||
| frameshift | 13 | 18 | 6 | 37 | ||
| splice donor/acceptor (+/-2bp) | 3 | 2 | 3 | 8 | ||
| Total | 27 | 39 | 175 | 70 | 6 | 317 |
Highest pathogenic variant AF is 0.0000031243517
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006485.2 | 4 | MANE Select | |
| Ensembl | ENSP00000222329.3 | 4 | MANE Select | |
| RefSeq | NP_001287964.1 | 3 | Standard | |
| RefSeq | NP_001295331.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Oncogene Induced Senescence
- Cellular Senescence
- Cellular responses to stress
- Cellular responses to external stimuli
Biological Process
- negative regulation of transcription by RNA polymerase II
- mitotic cell cycle
- regulation of transcription by RNA polymerase II
- cell differentiation
Molecular Function
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription repressor activity, RNA polymerase II-specific
- transcription corepressor activity
- sequence-specific DNA binding
Cellular Component
- nucleus
- nucleoplasm
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000222329
- Coding exons
- 4
- Length
- 7586
- Individuals with no LoFs
- 125719
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 4
- Defined
- 125723
- p
- 0.0000159
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 2.25 | 238 | 358 | 0.665 | 0.0000242 | 3427 |
| Missense (PolyPhen) | 49 | 110.47 | 0.44354 | 1066 | ||
| Synonymous | -1.84 | 199 | 169 | 1.18 | 0.0000120 | 1236 |
| Loss of Function | 3.73 | 1 | 18.2 | 0.0551 | 0.00000101 | 196 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000028 | 0.000026 | rare |
| South Asian | 0 | 0.0 | absent |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Potent transcriptional repressor that binds to the H1 element of the Ets2 promoter. May regulate other genes involved in cellular proliferation. Required for extraembryonic ectoderm differentiation, ectoplacental cone cavity closure, and chorioallantoic attachment (By similarity). May be important for regulating trophoblast stem cell differentiation (By similarity). {ECO:0000250}.;
- Disease
- DISEASE: Craniosynostosis 4 (CRS4) [MIM:600775]: A primary abnormality of skull growth involving premature fusion of one or more cranial sutures. The growth velocity of the skull often cannot match that of the developing brain resulting in an abnormal head shape and, in some cases, increased intracranial pressure, which must be treated promptly to avoid permanent neurodevelopmental disability. {ECO:0000269|PubMed:23354439}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Chitayat syndrome (CHYTS) [MIM:617180]: An autosomal dominant syndrome characterized by hyperphalangism, partial syndactyly, bilateral accessory phalanx resulting in shortened index fingers, hallux valgus, brachydactyly, facial anomalies, diffuse bronchomalacia, and respiratory distress at birth and in infancy. {ECO:0000269|PubMed:27738187}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.139
Intolerance Scores
- LoFtool
- 0.0200
- RVIS EVS
- -0.42
- RVIS percentile EVS
- 25.56
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.994
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |